Used primarily as an intermediate in the synthesis of semi-synthetic macrolide antibiotics, this compound plays a key role in enhancing metabolic stability and bioavailability in antibiotic development. It serves as a building block for derivatives with improved activity against resistant bacterial strains, particularly in the creation of next-generation erythromycin analogs. Its modified sugar moieties increase acid stability, allowing for better oral absorption in final drug formulations. Commonly employed in research and pharmaceutical manufacturing to develop antibiotics targeting respiratory tract infections, skin infections, and other bacterial diseases.